Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionglycogen phosphorylase activity

PYGB PYGM

3.84e-053722GO:0008184
GeneOntologyMolecularFunction1,4-alpha-oligoglucan phosphorylase activity

PYGB PYGM

1.27e-045722GO:0004645
DomainPHOSPHORYLASE

PYGB PYGM

4.14e-053702PS00102
DomainPhosphorylase

PYGB PYGM

4.14e-053702PF00343
DomainGlycg_phsphrylas

PYGB PYGM

4.14e-053702IPR011833
DomainGlyco_trans_35

PYGB PYGM

4.14e-053702IPR000811
DomainTF_T-box

TBX22 TBX2

1.82e-0317702IPR001699
DomainTBOX

TBX22 TBX2

1.82e-0317702SM00425
DomainTF_T-box_CS

TBX22 TBX2

1.82e-0317702IPR018186
Domain-

TBX22 TBX2

1.82e-03177022.60.40.820
DomainTBOX_3

TBX22 TBX2

1.82e-0317702PS50252
DomainT-box

TBX22 TBX2

1.82e-0317702PF00907
DomainTBOX_1

TBX22 TBX2

1.82e-0317702PS01283
DomainTBOX_2

TBX22 TBX2

1.82e-0317702PS01264
Pubmed

Genetically determined murine models of immunodeficiency.

ASIP KIT LYST

5.14e-0787433297105
Pubmed

RNA binding proteins co-localize with small tau inclusions in tauopathy.

HK1 TKT ACTR10 HSPH1 AP3B2 PYGB PYGM

2.48e-0628374730068389
Pubmed

Mutations in mice that influence natural killer (NK) cell activity.

ASIP KIT LYST

3.31e-06147436971254
Pubmed

Knockdown of Musashi RNA Binding Proteins Decreases Radioresistance but Enhances Cell Motility and Invasion in Triple-Negative Breast Cancer.

MSI1 MSI2

4.47e-06274232245259
Pubmed

IL-33 exacerbates autoantibody-induced arthritis.

IL1RL1 KIT

4.47e-06274220139274
Pubmed

The ubiquitin ligase adaptor Ndfip1 regulates T cell-mediated gastrointestinal inflammation and inflammatory bowel disease susceptibility.

ASIP NDFIP1

4.47e-06274220962770
Pubmed

The RNA-binding protein Musashi is required intrinsically to maintain stem cell identity.

MSI1 MSI2

4.47e-06274216717192
Pubmed

Theoretical studies on RNA recognition by Musashi 1 RNA-binding protein.

MSI1 MSI2

4.47e-06274235840700
Pubmed

Embryonic Hematopoietic Progenitor Cells Reside in Muscle before Bone Marrow Hematopoiesis.

PTPRC KIT

4.47e-06274226389592
Pubmed

A new assay method for late CFU-S formation and long-term reconstituting activity using a small number of pluripotent hemopoietic stem cells.

PTPRC KIT

4.47e-06274212004082
Pubmed

Dysregulated Stem Cell Markers Musashi-1 and Musashi-2 are Associated with Therapy Resistance in Inflammatory Breast Cancer.

MSI1 MSI2

4.47e-06274237481823
Pubmed

Assessment of MUSASHI 1 and MUSASHI 2 expression in spermatozoa and testicular tissue.

MSI1 MSI2

4.47e-06274234309875
Pubmed

Interplay between the RNA binding-protein Musashi and developmental signaling pathways.

MSI1 MSI2

4.47e-06274231692135
Pubmed

C-kit+ CD45- cells found in the adult human heart represent a population of endothelial progenitor cells.

PTPRC KIT

4.47e-06274220119835
Pubmed

Dual Knockdown of Musashi RNA-Binding Proteins MSI-1 and MSI-2 Attenuates Putative Cancer Stem Cell Characteristics and Therapy Resistance in Ovarian Cancer Cells.

MSI1 MSI2

4.47e-06274234768932
Pubmed

MTOR inhibition enhances NVP-AUY922-induced autophagy-mediated KIT degradation and cytotoxicity in imatinib-resistant gastrointestinal stromal tumors.

MTOR KIT

4.47e-06274225375091
Pubmed

INPP4B overexpression and c-KIT downregulation in human achalasia.

KIT INPP4B

4.47e-06274229644781
Pubmed

Crystal and solution structures of human oncoprotein Musashi-2 N-terminal RNA recognition motif 1.

MSI1 MSI2

4.47e-06274231603583
Pubmed

Expression of RNA-binding protein Musashi in hair follicle development and hair cycle progression.

MSI1 MSI2

4.47e-06274216400011
Pubmed

Linkage studies with the pirouette gene in the mouse.

GRXCR1 KIT

4.47e-06274220281716
Pubmed

The Musashi proteins MSI1 and MSI2 are required for photoreceptor morphogenesis and vision in mice.

MSI1 MSI2

4.47e-06274233168629
Pubmed

Msi RNA-binding proteins control reserve intestinal stem cell quiescence.

MSI1 MSI2

4.47e-06274227799368
Pubmed

Musashi 2 is a regulator of the HSC compartment identified by a retroviral insertion screen and knockout mice.

PTPRC MSI2

4.47e-06274221613258
Pubmed

Musashi proteins are post-transcriptional regulators of the epithelial-luminal cell state.

MSI1 MSI2

4.47e-06274225380226
Pubmed

Musashi expression in β-cells coordinates insulin expression, apoptosis and proliferation in response to endoplasmic reticulum stress in diabetes.

MSI1 MSI2

4.47e-06274222113197
Pubmed

Musashi RNA-Binding Proteins as Cancer Drivers and Novel Therapeutic Targets.

MSI1 MSI2

4.47e-06274228143872
Pubmed

Knockout of RNA Binding Protein MSI2 Impairs Follicle Development in the Mouse Ovary: Characterization of MSI1 and MSI2 during Folliculogenesis.

MSI1 MSI2

4.47e-06274226131972
Pubmed

RNA-binding protein Musashi family: roles for CNS stem cells and a subpopulation of ependymal cells revealed by targeted disruption and antisense ablation.

MSI1 MSI2

4.47e-06274212407178
Pubmed

Identification of a yolk sac cell population with hematopoietic activity in view of CD45/c-Kit expression.

PTPRC KIT

4.47e-06274221883169
Pubmed

mTOR regulates the nucleoplasmic diffusion of Xrn2 under conditions of heat stress.

XRN2 MTOR

4.47e-06274225128458
Pubmed

RNA binding proteins in spermatogenesis: an in depth focus on the Musashi family.

MSI1 MSI2

4.47e-06274225851660
Pubmed

Isoform-selective regulation of glycogen phosphorylase by energy deprivation and phosphorylation in astrocytes.

PYGB PYGM

4.47e-06274225130497
Pubmed

Natural product derivative Gossypolone inhibits Musashi family of RNA-binding proteins.

MSI1 MSI2

4.47e-06274230097032
Pubmed

Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.

XRN2 HK1 INCENP UBR5 MTOR PYGB FH ZMYM3 RAI1

1.02e-0565374922586326
Pubmed

IL-33 induces skin inflammation with mast cell and neutrophil activation.

IL1RL1 KIT

1.34e-05374221674479
Pubmed

Translationally controlled tumor protein interacts with the third cytoplasmic domain of Na,K-ATPase alpha subunit and inhibits the pump activity in HeLa cells.

TPT1 ATP1A2

1.34e-05374215383549
Pubmed

Immunolocalization of stem/progenitor cell biomarkers Oct-4, C-kit and Musashi-1 in endometriotic lesions.

MSI1 KIT

1.34e-05374234468911
Pubmed

Formation of Toxic Oligomeric Assemblies of RNA-binding Protein: Musashi in Alzheimer's disease.

MSI1 MSI2

1.34e-05374230367664
Pubmed

The Musashi proteins direct post-transcriptional control of protein expression and alternate exon splicing in vertebrate photoreceptors.

MSI1 MSI2

1.34e-05374236153373
Pubmed

Endothelin 3 induces skin pigmentation in a keratin-driven inducible mouse model.

ASIP KIT

1.34e-05374217611578
Pubmed

Linkage groups 3 and XVII in the mouse and the position of the light-ear locus.

GRXCR1 KIT

1.34e-0537426031678
Pubmed

Dorsoventral patterning of the mouse coat by Tbx15.

TBX22 ASIP

1.34e-05374214737183
Pubmed

IL-33 activates B1 cells and exacerbates contact sensitivity.

IL1RL1 KIT

1.34e-05374221239718
Pubmed

Tau oligomers mediate aggregation of RNA-binding proteins Musashi1 and Musashi2 inducing Lamin alteration.

MSI1 MSI2

1.34e-05374231532069
Pubmed

The Alarmin IL-33 Derived from HSV-2-Infected Keratinocytes Triggers Mast Cell-Mediated Antiviral Innate Immunity.

IL1RL1 KIT

1.34e-05374226872602
Pubmed

Increased SCF/c-kit by hypoxia promotes autophagy of human placental chorionic plate-derived mesenchymal stem cells via regulating the phosphorylation of mTOR.

MTOR KIT

1.34e-05374222833529
Pubmed

mTOR, VEGF, PDGFR, and c-kit signaling pathway activation in Kaposi sarcoma.

MTOR KIT

1.34e-05374228506734
Pubmed

Loss of c-kit accompanies B-lineage commitment and acquisition of CD45R by most murine B-lymphocyte precursors.

PTPRC KIT

1.34e-05374210397738
Pubmed

Site of beige (bg) and leaden (ln) pigment gene expression determined by recombinant embryonic skin grafts and aggregation mouse chimaeras employing sash (Wsh) homozygotes.

KIT LYST

1.34e-0537423910518
Pubmed

RNA-binding proteins Musashi and tau soluble aggregates initiate nuclear dysfunction.

MSI1 MSI2

1.34e-05374232855391
Pubmed

Lack of Phenotypical and Morphological Evidences of Endothelial to Hematopoietic Transition in the Murine Embryonic Head during Hematopoietic Stem Cell Emergence.

PTPRC KIT

1.34e-05374227227884
Pubmed

Blind-sterile: a new mutation on chromosome 2 of the house mouse.

ASIP KIT

1.34e-0537426863898
Pubmed

Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification.

TPT1 PITRM1 UBR5 MTOR TKT HSPH1 FH AHNAK2

1.92e-0553874828524877
Pubmed

PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.

PHF2 LENG8 DNAJB1 TPT1 XRN2 UBR5 TKT HSPH1 TPX2 ZMYM3 RAI1

2.09e-051103741134189442
Pubmed

The Musashi RNA binding proteins direct the translational activation of key pituitary mRNAs.

MSI1 MSI2

2.67e-05474238467682
Pubmed

PHF2 regulates sarcomeric gene transcription in myogenesis.

PHF2 MYBPC2

2.67e-05474238701072
Pubmed

The Nedd4-2/Ndfip1 axis is a negative regulator of IgE-mediated mast cell activation.

KIT NDFIP1

2.67e-05474227786273
Pubmed

IL-33 potentiates histaminergic itch.

IL1RL1 KIT

2.67e-05474237984799
Pubmed

An Interleukin-33-Mast Cell-Interleukin-2 Axis Suppresses Papain-Induced Allergic Inflammation by Promoting Regulatory T Cell Numbers.

IL1RL1 KIT

2.67e-05474226200013
Pubmed

IL-33 causes selective mast cell tolerance to bacterial cell wall products by inducing IRAK1 degradation.

IL1RL1 KIT

2.67e-05474223404570
Pubmed

Ndfip1 restricts mTORC1 signalling and glycolysis in regulatory T cells to prevent autoinflammatory disease.

MTOR NDFIP1

2.67e-05474228580955
Pubmed

Impaired development of melanoblasts in the black-eyed white Mitf(mi-bw) mouse, a model for auditory-pigmentary disorders.

PTPRC KIT

2.67e-05474222563733
Pubmed

RNA binding protein Musashi-1 directly targets Msi2 and Erh during early testis germ cell development and interacts with IPO5 upon translocation to the nucleus.

MSI1 MSI2

2.67e-05474225782991
Pubmed

Characterising the dynamics of placental glycogen stores in the mouse.

HK1 PYGB PYGM

3.25e-052974332798765
Pubmed

Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2.

BRCA2 UBR5 PYGB REV3L

3.68e-058774417148452
Pubmed

The Msi Family of RNA-Binding Proteins Function Redundantly as Intestinal Oncoproteins.

MSI1 MSI2

4.45e-05574226673327
Pubmed

Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity.

IL1RL1 KIT

4.45e-05574220200518
Pubmed

Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma.

MSI1 MSI2

4.45e-05574227281208
Pubmed

Transformation of the intestinal epithelium by the MSI2 RNA-binding protein.

MSI1 MSI2

4.45e-05574225774828
Pubmed

Hsp105 but not Hsp70 family proteins suppress the aggregation of heat-denatured protein in the presence of ADP.

DNAJB1 HSPH1

4.45e-05574214644449
Pubmed

Musashi Exerts Control of Gonadotrope Target mRNA Translation During the Mouse Estrous Cycle.

MSI1 MSI2

4.45e-05574237477898
Pubmed

Aurora kinase-A regulates kinetochore/chromatin associated microtubule assembly in human cells.

INCENP TPX2

4.45e-05574218773538
Pubmed

Dissection of the c-Kit signaling pathway in mouse primordial germ cells by retroviral-mediated gene transfer.

MTOR KIT

4.45e-05574212140361
Pubmed

Coactivator-associated arginine methyltransferase 1 regulates fetal hematopoiesis and thymocyte development.

PTPRC KIT

4.45e-05574223248263
Pubmed

Linkage map of nine loci defined by polymorphic DNA markers assigned to rat chromosome 13.

PTPRC ATP1A2

4.45e-0557428288230
Pubmed

Developmental expression of Musashi-1 and Musashi-2 RNA-binding proteins during spermatogenesis: analysis of the deleterious effects of dysregulated expression.

MSI1 MSI2

4.45e-05574224671879
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

PHF2 DNAJB1 XRN2 DENND4A HK1 PITRM1 INCENP MTOR TKT HSPH1 LRRC40 FH

4.46e-051425741230948266
Pubmed

Requirement for the Mitochondrial Pyruvate Carrier in Mammalian Development Revealed by a Hypomorphic Allelic Series.

MTOR TKT PYGM FH

4.78e-059374427215380
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

TPT1 DENND4A HK1 TKT HSPH1 ATP1A2 PPIP5K2 CAMSAP2 LYST SLC4A11 RAI1 MYBPC2

5.00e-051442741235575683
Pubmed

Network organization of the huntingtin proteomic interactome in mammalian brain.

PHF2 HK1 BRCA2 MTOR HSPH1 AP3B2 PYGB PYGM

5.29e-0562174822794259
Pubmed

Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium.

HK1 TSHZ2 KIT

5.76e-053574319862010
Pubmed

Patients and mice with deficiency in the SNARE protein SYNTAXIN-11 have a secondary B cell defect.

PTPRC LYST

6.66e-05674238722309
Pubmed

The RNA-binding protein Musashi-1 is produced in the developing and adult mouse eye.

MSI1 MSI2

6.66e-05674217768378
Pubmed

The Role of SCL Isoforms in Embryonic Hematopoiesis.

PTPRC KIT

6.66e-05674237047400
Pubmed

The EMT regulator Zeb2/Sip1 is essential for murine embryonic hematopoietic stem/progenitor cell differentiation and mobilization.

PTPRC KIT

6.66e-05674221355089
Pubmed

Stat5 expression is critical for mast cell development and survival.

IL1RL1 KIT

6.66e-05674212714518
Pubmed

Hmgb3: an HMG-box family member expressed in primitive hematopoietic cells that inhibits myeloid and B-cell differentiation.

PTPRC KIT

6.66e-05674212714519
Pubmed

Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers.

BRCA2 TPX2

6.66e-05674225830658
Pubmed

A single amino acid change converts Aurora-A into Aurora-B-like kinase in terms of partner specificity and cellular function.

INCENP TPX2

6.66e-05674219357306
Pubmed

CD41 expression defines the onset of primitive and definitive hematopoiesis in the murine embryo.

PTPRC KIT

6.66e-05674212900455
Pubmed

Phenotype and hematopoietic potential of side population cells throughout embryonic development.

PTPRC KIT

6.66e-05674212805065
Pubmed

Ndfip1 enforces a requirement for CD28 costimulation by limiting IL-2 production.

ASIP NDFIP1

6.66e-05674223851689
Pubmed

N-cadherin+ HSCs in fetal liver exhibit higher long-term bone marrow reconstitution activity than N-cadherin- HSCs.

PTPRC KIT

6.66e-05674223092738
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

PHF2 LENG8 DNAJB1 HSPH1 TPX2 GON4L SRGAP2 CAMSAP2 TAF1L MRPL9 ZMYM3 TBX2

7.16e-051497741231527615
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

DNAJB1 DENND4A MTOR TBC1D22B SRGAP2 PPIP5K2 CAMSAP2 LYST AHNAK2

8.79e-0586174936931259
Pubmed

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.

ZBTB44 DENND4A TKT MYPN GON4L PYGM MYBPC2

9.19e-0549774723414517
Pubmed

Neural crest cell lineage segregation in the mouse neural tube.

PTPRC KIT

9.31e-05774215548576
Pubmed

BMP4/Smad5 dependent stress erythropoiesis is required for the expansion of erythroid progenitors during fetal development.

PTPRC KIT

9.31e-05774218374325
Pubmed

A novel HSF1-mediated death pathway that is suppressed by heat shock proteins.

DNAJB1 HSPH1

9.31e-05774217024176
Pubmed

Runx1 expression marks long-term repopulating hematopoietic stem cells in the midgestation mouse embryo.

PTPRC KIT

9.31e-05774212049718
InteractionPYGL interactions

HK1 PITRM1 TKT PYGB PYGM FH

6.12e-06125736int:PYGL
InteractionCCDC88B interactions

TSHZ2 FAM161B ZC2HC1C TBC1D22B

2.11e-0545734int:CCDC88B
InteractionASF1A interactions

PHF2 LENG8 XRN2 BRCA2 INCENP TPX2 RAI1

3.29e-05249737int:ASF1A
InteractionPMS1 interactions

HK1 BRCA2 UBR5 PYGB REV3L

3.95e-05105735int:PMS1
Cytoband13q12.3

BRCA2 HSPH1

5.80e-042274213q12.3
GeneFamilyGlycogen phosphorylases

PYGB PYGM

1.66e-053432437
GeneFamilyT-boxes

TBX22 TBX2

8.25e-0418432766
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LENG8 TSHZ2 HSPH1 TMPRSS4 SLC4A11 RAI1 MSI2

1.83e-081797376e965e424eebef50f0202cff75f458be395cfca1
ToppCell10x5'-lymph-node_spleen-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|lymph-node_spleen / Manually curated celltypes from each tissue

DNAJB1 TPT1 TSHZ2 HSPH1 INPP4B NDFIP1

8.45e-07196736c945dc6c56c61732e065daaad7e6f48c02ee183c
ToppCellnormal_Lymph_Node-T/NK_cells|normal_Lymph_Node / Location, Cell class and cell subclass

DNAJB1 TPT1 PTPRC TSHZ2 INPP4B NDFIP1

8.71e-071977369d2dbf86e67d498e058e00bd1af73e16306dda0b
ToppCell10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive_helper_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

DNAJB1 TPT1 PTPRC TSHZ2 INPP4B NDFIP1

8.97e-07198736c4d8d133e571ad3a7c5de93aa7befb67cb7a003d
ToppCell10x5'-lymph-node_spleen-Lymphocytic_T_CD4|lymph-node_spleen / Manually curated celltypes from each tissue

DNAJB1 TPT1 PTPRC TSHZ2 INPP4B NDFIP1

8.97e-071987362cbafcb03df3c9aca68371df500d18ab8dcc416c
ToppCellmLN-T_cell|mLN / Region, Cell class and subclass

DNAJB1 TPT1 PTPRC TSHZ2 INPP4B NDFIP1

9.24e-07199736caa37ec509b54e842564d754f100ab1b2a77a7c1
ToppCellmLN-(1)_T_cell|mLN / shred on region, Cell_type, and subtype

DNAJB1 TPT1 PTPRC TSHZ2 INPP4B NDFIP1

9.24e-071997364bf2641409c543c2167bff71efa95b00dd7bfe19
ToppCell3'_v3-bone_marrow-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|bone_marrow / Manually curated celltypes from each tissue

DNAJB1 TPT1 TSHZ2 HSPH1 NDFIP1

2.30e-06129735426dfed68ce7ccc38d02e671e722e201f9eb1ce0
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TSHZ2 ATP1A2 ABCA8 MYBPC2 CEMIP

4.82e-061507351270f33f9d7e46e55adf1a96e8beee858b95589d
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TSHZ2 ATP1A2 ABCA8 MYBPC2 CEMIP

4.82e-06150735156118ce1d69522624196410cba18b8354cd0bb4
ToppCell343B-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

ZCCHC18 DNAJB1 IL1RL1 KIT AHNAK2

7.89e-061667354e47e7f3019fb2dcbc35b4e9b47ee265a97cec5c
ToppCell343B-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

ZCCHC18 DNAJB1 IL1RL1 KIT AHNAK2

7.89e-06166735f6e2ec767c022982ef416fadb998a7b6b958f76a
ToppCellPND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

INCENP TPX2 CCDC168 IL1RL1 INPP4B

8.37e-06168735a7eb28e15b591997f1aee09501cb20ae18beca08
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

DNAJB1 TSHZ2 HSPH1 INPP4B NDFIP1

1.17e-05180735f3d35b2ea78afef37a84232adf5e6e26712b618d
ToppCellPericytes-Donor_03|World / lung cells shred on cell class, cell subclass, sample id

PYGM CCDC168 ATP1A2 INPP4B TBX2

1.27e-05183735d04deef7cd4e1738227a6593b84874ce0168c773
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

DNAJB1 PDE9A PHOSPHO2 INPP4B NDFIP1

1.33e-05185735847257d232b9993cad50c814fd4ffeef52385295
ToppCell343B-Lymphocytic-CD4_T-cell|343B / Donor, Lineage, Cell class and subclass (all cells)

DNAJB1 TPT1 PTPRC TSHZ2 INPP4B

1.37e-05186735f6743d1f1d57d9d9a4581a88f156078a1da46816
ToppCell10x5'-bone_marrow-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated|bone_marrow / Manually curated celltypes from each tissue

DNAJB1 TPT1 TSHZ2 HSPH1 INPP4B

1.37e-051867355108d9b7a081876ca34594b110d58df56063f542
ToppCelltumor_Lung-B_lymphocytes-Undetermined|B_lymphocytes / Location, Cell class and cell subclass

DNAJB1 SLC2A4RG PTPRC DRAP1 INPP4B

1.52e-05190735e3ba8d36e0ad9525912b1891922573b55a1d5ed9
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)

DNAJB1 TSHZ2 HSPH1 INPP4B NDFIP1

1.56e-051917359bb6a6b88f351217455765ba07a6acf11fda98f4
ToppCellsevere_COVID-19-CD4+_Tcm|severe_COVID-19 / disease group, cell group and cell class (v2)

DNAJB1 TPT1 SLC2A4RG TSHZ2 INPP4B

1.56e-051917351ec86eaf90411ed200dbf51ae0cb5ed8060a7ec7
ToppCellhuman_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells)

DNAJB1 XRN2 UBR5 HSPH1 MSI2

1.59e-05192735916fbec1c7ab7969bda711886ac88e877e30c280
ToppCell10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

DENND4A PTPRC TSHZ2 HSPH1 INPP4B

1.59e-0519273547646d7e4990be85072987f92bf18d52f8da752e
ToppCellmild_COVID-19-CD4+_T_naive|mild_COVID-19 / disease group, cell group and cell class (v2)

DNAJB1 TPT1 TSHZ2 INPP4B NDFIP1

1.63e-0519373540fc4a519c883c6c269a9c05be36ae906f75426a
ToppCellmild_COVID-19-CD4+_T_naive|World / disease group, cell group and cell class (v2)

DNAJB1 TPT1 TSHZ2 INPP4B NDFIP1

1.63e-0519373542ddacc55658ea6ba4248ac19c9c3709f342b4f5
ToppCellhuman_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells)

DNAJB1 XRN2 UBR5 HSPH1 MSI2

1.63e-05193735e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCellPBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

DNAJB1 TPT1 TSHZ2 INPP4B NDFIP1

1.68e-051947352e2019a7bf57f257f0ff9b24eacff59dbb952ebb
ToppCellPBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

DNAJB1 TPT1 TSHZ2 INPP4B NDFIP1

1.68e-05194735d788d5bd1e651706e7e2d54ada546a5e84f86ff0
ToppCellT/NK_cells-Regulatory_T_cell|World / Lineage and Cell class

DNAJB1 TPT1 PTPRC TSHZ2 INPP4B

1.68e-051947354f55da763f63d1bf6379582e9d85796a797c5b76
ToppCellT/NK_cells-CD4+_Naive_T_cell|World / Lineage and Cell class

DNAJB1 TPT1 TSHZ2 INPP4B NDFIP1

1.68e-051947354c6cdedf35c5416a52cb931637715b23d5d07996
ToppCellPBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DNAJB1 TPT1 TSHZ2 INPP4B NDFIP1

1.68e-05194735e0ccf18edbae09fc1068f1e923f1bc0d0ff44195
ToppCellPBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DNAJB1 TPT1 TSHZ2 INPP4B NDFIP1

1.68e-05194735fc0504730ae576ff46ba0bc9f585c53ab78d914c
ToppCellControl-Lymphoid_T/NK-CD4+_T_naive|Control / Disease group, lineage and cell class

DNAJB1 TPT1 TSHZ2 INPP4B NDFIP1

1.68e-05194735aabcd9f71d8ef54add5c46d8a3e226e3ae3ab124
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

DNAJB1 TPT1 TSHZ2 INPP4B NDFIP1

1.72e-05195735e4caa01d2040a6f4dd90e68c2e1e99c5405e2eba
ToppCellPBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)

DNAJB1 TPT1 TSHZ2 INPP4B NDFIP1

1.72e-051957359c71d2a58e772b556e22e2f1d60593580b7aafd8
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

DNAJB1 TPT1 TSHZ2 INPP4B NDFIP1

1.76e-05196735ffc2728663a72ec62fa2e5b1054368fb56d18c62
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

DNAJB1 TPT1 PTPRC INPP4B NDFIP1

1.80e-05197735b044833de12f2b9eb702155563cd8932bc16e0ef
ToppCellsevere-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

PTPRC TSHZ2 IL1RL1 INPP4B MSI2

1.80e-0519773557ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCellnormal_Lymph_Node-T/NK_cells-Naive_CD4+_T|normal_Lymph_Node / Location, Cell class and cell subclass

DNAJB1 TPT1 TSHZ2 INPP4B NDFIP1

1.80e-05197735a25954c534da16d5ce57cfe3a3a01beb2f556a5c
ToppCellPBMC-Mild-Lymphocyte-T/NK-CD4+_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

DNAJB1 TPT1 TSHZ2 INPP4B NDFIP1

1.80e-05197735442fb5ee17e6d4d8c280721b21fd3f7ba6475951
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

DNAJB1 TPT1 TSHZ2 INPP4B NDFIP1

1.80e-05197735076fc05b32200e0a8a1e35d03c295111468d92a9
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_T_CD4|lymph-node_spleen / Manually curated celltypes from each tissue

DNAJB1 TPT1 TSHZ2 INPP4B NDFIP1

1.80e-051977359a097ad32795e27153448e9a54989455d062a20a
ToppCell10x3'2.3-week_14-16-Myeloid_neutrophil-granulo|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

TPT1 PTPRC TKT IL1RL1 LYST

1.85e-05198735822df797fffbedf63ff8a8d99ea57511ce55f7cf
ToppCell(23)_CD4+_T_cell|World / immune cells in Peripheral Blood (logTPM normalization)

DNAJB1 TPT1 TSHZ2 INPP4B NDFIP1

1.85e-05198735c1a76f9e7ea661933854754ec5a0fcaf2585466e
ToppCell10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

DNAJB1 SLC2A4RG PTPRC INPP4B NDFIP1

1.85e-05198735db107a5511571384f26e26c6301aef9a9f2423c4
ToppCellmLN-(1)_T_cell-(14)_Tcm|mLN / shred on region, Cell_type, and subtype

DNAJB1 TPT1 TSHZ2 INPP4B NDFIP1

1.89e-051997353222454da504e119c78e666b90cc669ff0335b1a
ToppCellmLN-T_cell-Tcm|mLN / Region, Cell class and subclass

DNAJB1 TPT1 TSHZ2 INPP4B NDFIP1

1.89e-05199735b1237c8d1acad6737d8cb425dc4eb50724e2302c
ToppCellControl-Control-Lymphocyte-T/NK-CD4+_T_naive|Control / Disease, condition lineage and cell class

DNAJB1 TPT1 TSHZ2 INPP4B NDFIP1

1.94e-0520073559b446cd886767f19553aed779ab313685789f6f
ToppCell10x5'-GI_large-bowel-Lymphocytic_T_CD4|GI_large-bowel / Manually curated celltypes from each tissue

PTPRC TSHZ2 HSPH1 INPP4B NDFIP1

1.94e-0520073542403d59b65d4b3ba6aa4aaf2d7252176067fba5
ToppCellcontrol-CD4+_T_naive|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

DNAJB1 TPT1 TSHZ2 INPP4B NDFIP1

1.94e-052007350adb8dc3188c07a4871c6d524aab8f45dff0b14e
ToppCell(14)_Tcm|World / shred on Cell_type and subtype

TPT1 PTPRC TSHZ2 INPP4B NDFIP1

2.29e-052077355521742c28b99d5e3119da11bd56a33bd4243bb3
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Vipr2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

PYGM KIT INPP4B CEMIP

8.27e-0514073472c272f44e5600b3037c1dbf9d3a4669a35588d8
ToppCellCOVID-19-Heart-CM_5_(RYR2-)|COVID-19 / Disease (COVID-19 only), tissue and cell type

MYPN PYGM ATP1A2 MYBPC2

9.23e-05144734f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf
ToppCellPND07-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DENND4A INCENP TPX2 MYBPC2

9.73e-0514673445d7cb73776e60d22f335a651845e21e16948fcc
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

DNAJB1 TSHZ2 INPP4B NDFIP1

9.99e-05147734463af96748349c8fec2911b353a7e7e4cb072280
ToppCellP28-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase

ZBTB44 TPX2 MSI1 MYBPC2

1.20e-0415473444d4d99b08216c0901e3bc32743fa0a8b85b5149
ToppCellfacs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SLC7A9 PYGM IL1RL1 MSI1

1.20e-041547345ed64bbf603290e6dc34f81d145982690b89dd0d
ToppCellsevere_influenza-CD4+_T_naive|World / disease group, cell group and cell class (v2)

TPT1 TSHZ2 INPP4B NDFIP1

1.32e-041587348ab3d8a9b7a1daa890d76dde1d6182af40b70021
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TSHZ2 ABCA8 INPP4B CEMIP

1.35e-04159734e812cbde59188924c6277c3feadf1a9592fa62a4
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

TSHZ2 ABCA8 INPP4B CEMIP

1.35e-041597342607b562903228274fbd96168ba826782fab0b53
ToppCell368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)

PHF2 TSHZ2 CCDC168 KIT

1.39e-0416073419105debef96ea0c267d6a1d332303ec668ae47e
ToppCell343B-Myeloid-Mast_cell|343B / Donor, Lineage, Cell class and subclass (all cells)

DNAJB1 HSPH1 IL1RL1 KIT

1.39e-04160734133ecae0a894d9a0d49d58859623359096b6f030
ToppCellPND07-Immune-Immune_Myeloid-Granulocytic-Mast-Mast_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

IL1RL1 KIT INPP4B AHNAK2

1.39e-041607345d22c86deead516444349d495998e04586be4396
ToppCell343B-Myeloid-Mast_cell-|343B / Donor, Lineage, Cell class and subclass (all cells)

DNAJB1 HSPH1 IL1RL1 KIT

1.39e-04160734a2f09b5955602819c8978f4372130c8ef915cd07
ToppCellPND07-Immune-Immune_Myeloid-Granulocytic-Mast|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

IL1RL1 KIT INPP4B AHNAK2

1.39e-04160734ca212634cf1875238071d1800ecdf34979a553fb
ToppCell343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

DNAJB1 TPT1 HSPH1 INPP4B

1.39e-0416073421f7c0337fbd99e4a20650920d8302d7318bd25e
ToppCelldroplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

DNAJB1 PTPRC RAB26 INPP4B

1.45e-0416273416f9fbcaa0093ffc5a2a5e32db6040e2cb519d47
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

TSHZ2 GDPD3 INPP4B CEMIP

1.45e-0416273468c40d12689cc1b6c797e6e48173f0110f8144e4
ToppCellPBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)

DNAJB1 TSHZ2 REV3L INPP4B

1.45e-0416273480317c4253bf8e897782e562f29835f181c65b98
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

TSHZ2 GDPD3 INPP4B CEMIP

1.45e-04162734735fa3f77b31a4189e431d05c326403c18cbbffb
ToppCellICU-SEP-Lymphocyte-T_NK-CD4_Naive|ICU-SEP / Disease, Lineage and Cell Type

TPT1 PDE9A TSHZ2 TRIM6

1.49e-04163734415e67aaae7ccd97a003b4b31b27eed94737deca
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Tpbg|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

PDE9A MYPN INPP4B CEMIP

1.52e-04164734f0499e6c1b17c4df72b18b294e3b53ef723da2ac
ToppCellChildren_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

ZCCHC18 ATP1A2 INPP4B TBX2

1.56e-041657348a82e20c9b1156bb4bbc16f7785abb04458d671b
ToppCellPND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PTPRC INCENP TPX2 INPP4B

1.60e-04166734a41a20cef053c67da2d435e3e132ce28f1661c03
ToppCellDividing_Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id

BRCA2 INCENP TPX2 TBX2

1.60e-04166734c503036f3c19ef186e1e62c9643c49dea3827f51
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Tpbg|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

PDE9A MYPN INPP4B CEMIP

1.60e-04166734b4241f8d2a0aa910dbb0d0d5d3631a9b73453fe9
ToppCell10x5'-Liver-Lymphocytic_T_CD4-Tnaive/CM_CD4|Liver / Manually curated celltypes from each tissue

TPT1 TSHZ2 PKD1L1 NDFIP1

1.63e-04167734ab6273ae5d76a3f9a05c58320e3dee80f9b99e47
ToppCellPND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CFAP47 PTPRC INCENP ASIP

1.71e-04169734b08567ecfa3f8d83e7990330fc1b27f0bb7e75a1
ToppCellwk_15-18-Epithelial-Proximal_epithelial-Pulmonary_NE_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

AP3B2 TMPRSS4 CCDC168 AMER3

1.75e-0417073498d13dbd76a826e47d55553f9d11f71c043b573e
ToppCellPND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

PTPRC INCENP TPX2 INPP4B

1.75e-04170734a0d6466e00bd3dc07f644ba3f87d5b421fd479d5
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

BRCA2 TSHZ2 TPX2 INPP4B

1.79e-04171734b0373ed8283ee1792b6a490bff93906546978593
ToppCell3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue

DENND4A PTPRC HSPH1 INPP4B

1.79e-041717342e9a20f8980b78325c52065a9c14ab3656267c05
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

BRCA2 TSHZ2 TPX2 INPP4B

1.79e-04171734b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55
ToppCellThalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora-Excitatory_Neuron.Slc17a6.Rora.Cbln2_(Neuron.Slc17a6.Rora.Cbln2)|Thalamus / BrainAtlas - Mouse McCarroll V32

MYPN TMPRSS4 AHNAK2

1.82e-04677335202166895fd109ad0d7584fc35c74814a59ce2b
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TSHZ2 IL1RL1 ATP1A2 ABCA8

1.83e-041727341ef243bce63d841c25e4b74d029d1377f84bcc3d
ToppCellkidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TSHZ2 IL1RL1 ATP1A2 ABCA8

1.83e-04172734ab1c81be29f93ca8920c6ab5ab92f497a9256d3f
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.4|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

GDPD3 TMPRSS4 PYGB SLC4A11

1.87e-04173734176b956e71d98e8275d698b39437fc326e5fe449
ToppCellfacs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

PHF2 DENND4A MTOR TMPRSS4

1.91e-04174734f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PTPRC BRCA2 INCENP TPX2

1.91e-041747347b318796728001c17b4043d2b033330c7be40c78
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LENG8 TMPRSS4 SLC4A11 CEMIP

1.91e-04174734207aa0118633cbe9a65839bbb1bb3ba9f8118ad2
ToppCellwk_20-22-Hematologic-Myeloid-Promonocyte-like|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

BRCA2 TKT TPX2 LYST

1.95e-04175734654299df246debe0a5b12f0d9568eb828bb94bb9
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

PTPRC BRCA2 INCENP TPX2

1.95e-04175734f7d191cde68de8f3457fa62b1df53b6d0dbe5001
ToppCellE18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

INCENP TPX2 MSI1 TBX2

1.95e-04175734a154b28b0b2180652d51d4c7d804b3b81b35899e
ToppCell5'-Adult-SmallIntestine-Hematopoietic-T_cells-SELL+_CD4_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

ZCCHC18 DNAJB1 TSHZ2 INPP4B

2.00e-04176734ac83a6cd4bcbb9ca1fc02a9fbd9d9629ef1df8ca
ToppCell3'_v3-blood-Mast-Mast_cells|blood / Manually curated celltypes from each tissue

ZC3H11B IL1RL1 KIT MSI2

2.00e-04176734b9da3deaf62622d47eb30b6be7548253eee95597
ToppCelldroplet-Marrow-BM-30m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

IL1RL1 ATP1A2 INPP4B TBX2

2.00e-041767348e4600efeea095a92178cfd26d7c58db7dfc0c80
ToppCellSevere-CD4+_T_activated|World / Disease group and Cell class

DNAJB1 TPT1 HSPH1 TMPRSS4

2.08e-04178734ef6111238703579a34bd6948bd9d4ca6b7e16063
ToppCell3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD4-positive,_alpha-beta_T_cell-CD4_T_cells-CD4_T_cells_L.1.1.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DNAJB1 TPT1 PTPRC INPP4B

2.13e-0417973423e2ec64ff8384c29b9c0abfb05c4694a37c6a8e
ToppCell5'-Adult-SmallIntestine-Hematopoietic-T_cells-Activated_CD4_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

DNAJB1 PTPRC HSPH1 INPP4B

2.13e-0417973402218c048e4dec0c0a3d63d2abb4feb4c3e82697
ToppCellfacs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ZCCHC18 IL1RL1 RAB26 INPP4B

2.17e-041807345fdd10ffdf49f0e818f865ca095a3882b35c640e
Drugphenylurethane

HK1 PYGB PYGM

6.54e-0612723CID000007591
DrugZM447439

INCENP MTOR AP3B2

2.00e-0517723CID009914412
DrugNSC633770

TKT TMPRSS4 PYGB PYGM

2.05e-0551724CID000003183
Drug3,5-dimethylphenyl isocyanate

PYGB PYGM

2.95e-053722CID000521488
Drug5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone

PYGB PYGM

2.95e-053722CID000093111
Drugadenosine-5'-chloromethylphosphonate

PYGB PYGM

2.95e-053722CID000191554
Drughydan

PYGB PYGM

2.95e-053722CID000008360
DrugEHMF

PYGB PYGM

2.95e-053722CID000033931
Drug5'-deoxy-5'-fluoro-5'-(methylthio)adenosine

PYGB PYGM

2.95e-053722CID000147839
Drugpyridoxal 5'-methylenephosphonate

PYGB PYGM

2.95e-053722CID003082249
DrugPlp 5'-mpa

PYGB PYGM

2.95e-053722CID003082151
Drugglucose-1,2-cyclic phosphate

PYGB PYGM

2.95e-053722CID000191723
Drug3'-FFdUrd

PYGB PYGM

2.95e-053722CID000072260
Drug2',3',4',5,5'-pentachloro-2-biphenylol

PYGB PYGM

2.95e-053722CID000119518
DrugAC1L8XK3

PYGB PYGM

2.95e-053722CID000409735
DrugN-acetyl-N'-beta-D-glucopyranosyl urea

PYGB PYGM

2.95e-053722CID000446801
DrugNSC758405

PYGB PYGM

2.95e-053722CID000003201
Drug3,5-dinitrophenyl phosphate

PYGB PYGM

2.95e-053722CID000151920
Drugriboflavin tetraacetate

PYGB PYGM

2.95e-053722CID000094186
Drugpyridoxal phosphoglucose

PYGB PYGM

2.95e-053722CID000196007
Drug2,5-dimethyl-3-furanone

PYGB PYGM

2.95e-053722CID000085730
Drug3,5-dinitrophenol

PYGB PYGM

2.95e-053722CID000011459
Drugrosiglitazone maleate; Down 200; 10uM; HL60; HG-U133A

SLC7A9 TPT1 PTPRC PITRM1 ATP1A2 TBX2

4.11e-05200726369_DN
Drug4-pyridoxic acid

TKT PYGB PYGM

5.13e-0523723CID000006723
DrugBrVarafUTP

PYGB PYGM REV3L

5.85e-0524723CID005273539
Druggalocitabine

PYGB PYGM

5.89e-054722CID000065950
Drug2,5-anhydro-D-mannitol 1-phosphate

PYGB PYGM

5.89e-054722CID000189134
DrugAC1LAMW2

PYGB PYGM

5.89e-054722CID000491364
DrugFdUrd-C8

PYGB PYGM

5.89e-054722CID000094262
DrugMem-CC

PYGB PYGM

5.89e-054722CID003081269
Drug5-deoxyribose-1-phosphate

PYGB PYGM

5.89e-054722CID000135786
Drugingliforib

PYGB PYGM

5.89e-054722CID006451325
Druguric acid riboside

PYGB PYGM

5.89e-054722CID000164933
Drugpseudo-dl-glucose

PYGB PYGM

5.89e-054722CID000125259
DrugAlpha-D-Glucose-6-Phosphate

HK1 PYGM

5.89e-054722DB02007
DrugBCIp4A

PYGB PYGM

5.89e-054722CID000192417
Drugpyridoxal diphosphate

PYGB PYGM

5.89e-054722CID000125696
Drug3'-chloromethotrexate

PYGB PYGM

5.89e-054722CID000097703
Drugneotrehalose

DNAJB1 HK1 SLC2A4RG MTOR PYGB PYGM

5.99e-05214726CID000001143
Drugheptulose-2-P

PYGB PYGM

9.80e-055722CID000124823
Drugm-anisidine

PYGB PYGM

9.80e-055722CID000010824
Drug6-FPLP

PYGB PYGM

9.80e-055722CID000146246
Druggluconohydroximo-1,5-lactone

PYGB PYGM

9.80e-055722CID009576855
Drug2-hydroxypropylphosphonate

PYGB PYGM

9.80e-055722CID000441028
DrugDHPBU

PYGB PYGM

9.80e-055722CID000125914
Drug6-FDPL

PYGB PYGM

9.80e-055722CID000129578
Drug5'-isobutylthioinosine

PYGB PYGM

9.80e-055722CID003080910
Drug3'-O-methylpyridoxal 5'-phosphate

PYGB PYGM

9.80e-055722CID003082179
DrugGlcMan

PYGB PYGM

9.80e-055722CID000152120
DrugU66985

PYGB PYGM

9.80e-055722CID000127224
Drugindirubin-5-sulphonate

PYGB PYGM

9.80e-055722CID005288641
DrugAC1O3M08

PYGB PYGM

9.80e-055722CID006331955
DrugAC1LCUXJ

PYGB PYGM

9.80e-055722CID000656425
Drug6-amino-5-bromouracil

PYGB PYGM

9.80e-055722CID000080578
Drugetafenone

PYGB PYGM

9.80e-055722CID000003275
DrugddEtUrd

PYGB PYGM

9.80e-055722CID000451452
Drug5-trifluoromethyl-2'-deoxycytidine

PYGB PYGM

9.80e-055722CID000125618
Drug1-o-phosphonohex-2-ulose

HK1 PYGB PYGM

1.04e-0429723CID000000481
Drug2-keto-3-deoxy-6-phosphogluconate

UBR5 TKT FH

1.16e-0430723CID000000046
Drug2,5-anhydro-D-mannitol

HK1 PYGB PYGM

1.28e-0431723CID000001494
DrugCV-araU

PYGB PYGM

1.47e-046722CID006441877
Drug2-thiothymidine

PYGB PYGM

1.47e-046722CID003005944
DrugCarbocyclic Bvdc

PYGB PYGM

1.47e-046722CID006438602
DrugDNPP

PYGB PYGM

1.47e-046722CID000067056
Drug5-chloro-indole-2-carboxylic acid

PYGB PYGM

1.47e-046722CID000082693
Drug2,2-dimethyl-3-hydroxybutyric acid

PYGB PYGM

1.47e-046722CID000152984
DrugEdUMP

PYGB PYGM

1.47e-046722CID003085112
Drug5'-deoxy-5'-chloroformycin

PYGB PYGM

1.47e-046722CID000126430
DrugNSC-97433

PYGB PYGM

1.47e-046722CID000001803
Drug5-n-propylthioadenosine

PYGB PYGM

1.47e-046722CID000656428
DrugAzddCyd

PYGB PYGM

1.47e-046722CID000451374
Drug5-Ffdru

PYGB PYGM

1.47e-046722CID000065561
DrugAR-L57

PYGB PYGM

1.47e-046722CID000156890
DrugCarbocyclic Ivdu

PYGB PYGM

1.47e-046722CID006439191
DrugClenbuterol hydrochloride [21898-19-1]; Up 200; 12.8uM; PC3; HT_HG-U133A

GDPD3 IL1RL1 KIT TBX2 CEMIP

1.93e-041687254671_UP
Drugalpha-(fluoromethyl)dehydroornithine

PYGB PYGM

2.05e-047722CID006439607
Drug6-fluoropyridoxal

PYGB PYGM

2.05e-047722CID003080803
Drug2',3'-dideoxy-3'-fluorocytidine

PYGB PYGM

2.05e-047722CID000356019
Drugheptenitol

PYGB PYGM

2.05e-047722CID000188267
DrugAC1L3372

PYGB PYGM

2.05e-047722CID000108025
Drug1 Gpt

PYGB PYGM

2.05e-047722CID000101247
Drugformycins

PYGB PYGM

2.05e-047722CID000512867
DrugPromonta

PYGB PYGM

2.05e-047722CID000108494
Drug5'-methylthioinosine

PYGB PYGM

2.05e-047722CID000161214
Drughydantocidin

PYGB PYGM

2.05e-047722CID000125429
DrugV0509

DNAJB1 HK1 SLC2A4RG MTOR PYGB PYGM

2.22e-04272726CID000102191
Druglithocholyltaurine

DNAJB1 SLC2A4RG MTOR PYGB PYGM

2.34e-04175725CID000010595
DrugL-BVAU

PYGB PYGM REV3L

2.36e-0438723CID000667554
Drugm189

HK1 MTOR PYGB PYGM FH

2.53e-04178725CID000022230
Drugdihydroxyacetone

HK1 TKT PYGB PYGM

2.65e-0498724CID000000670
Drugglutaconyl-CoA

ATP1A2 FH

2.73e-048722CID009543049
DrugAC1NUVX5

PYGB PYGM

2.73e-048722CID005461894
Drug6-methylpurine

PYGB PYGM

2.73e-048722CID005287547
Drugamorphin

PYGB PYGM

2.73e-048722CID000122792
DrugEtafenone [inn]

PYGB PYGM

2.73e-048722CID000066659
Drugdeoxyribose 5-phosphate

TKT PYGB PYGM

2.97e-0441723CID000000635
Drug6-o-phosphonohexose

DNAJB1 HK1 TKT PYGB PYGM

3.02e-04185725CID000099058
DrugCTK8G2960

DNAJB1 SLC2A4RG MTOR HSPH1 LYST

3.10e-04186725CID005361912
DrugMitoxantrone dihydrochloride [70476-82-3]; Up 200; 7.8uM; MCF7; HT_HG-U133A

TBC1D22B IL1RL1 ATP1A2 KIT AHNAK2

3.42e-041907253232_UP
Drug6-benzyl-2-thiouracil

PYGB PYGM

3.50e-049722CID000685814
Diseasemelanoma

BRCA2 INCENP ASIP DRAP1 KIT RAI1

2.77e-05248706C0025202
Diseaseleiomyosarcoma (is_marker_for)

XRN2 KIT

8.27e-056702DOID:1967 (is_marker_for)
DiseaseMalignant neoplasm of kidney

TPT1 BRCA2 FH

1.69e-0445703C0740457
Diseasememory performance

DENND4A PDE9A TSHZ2 TMPRSS4 FH MSI2

4.24e-04409706EFO_0004874
Diseasemale infertility (implicated_via_orthology)

CFAP47 KIT

4.25e-0413702DOID:12336 (implicated_via_orthology)
DiseaseMalignant lymphoma, lymphocytic, intermediate differentiation, diffuse

UBR5 MTOR

6.52e-0416702C0334634
DiseasePancreatic carcinoma

BRCA2 INPP4B

9.24e-0419702C0235974
Diseasefreckles

ASIP MSI2

1.03e-0320702EFO_0003963
Diseasemean corpuscular hemoglobin concentration

XRN2 DENND4A HK1 SLC2A4RG PTPRC UBR5 GDPD3 GON4L NDFIP1

1.17e-031105709EFO_0004528
Diseasehemoglobin measurement, mean corpuscular hemoglobin

DENND4A PTPRC

1.24e-0322702EFO_0004509, EFO_0004527
Diseaseurate measurement

SLC7A9 TKT GON4L PYGB PYGM DRAP1 INPP4B CEMIP

1.25e-03895708EFO_0004531
DiseaseNeoplasm of the genitourinary tract

BRCA2 KIT

1.48e-0324702cv:C0042065
DiseaseAtaxia

HK1 PITRM1

1.61e-0325702C0004134

Protein segments in the cluster

PeptideGeneStartEntry
MPFVPAVAKSIPRKR

AMER3

136

Q8N944
IKPEERSMIFVTKCP

CDADC1

411

Q9BWV3
TERAVVDVPMPKKLF

CEMIP

1186

Q8WUJ3
IPVVFKDVIRPGMRR

DNAJB1

281

P25685
SVIKRAGMPKPVRVV

ACTR10

41

Q9NZ32
PRIAPDVLRKMAKSF

AP3B2

516

Q13367
EASMKKVVRPRTPLS

ASIP

76

P42127
SPLPMFRRTKQEIKS

DENND4A

731

Q7Z401
RFPPARIKKIMQTDE

DRAP1

11

Q14919
SAFMAPVPTKKRNLV

RAI1

1226

Q7Z5J4
KQRSMKAPSEPRFRL

RAB26

226

Q9ULW5
AFPRRAQPKMVTRTK

MSI2

96

Q96DH6
SKDPRRMKALVPVTS

KIAA0895

146

Q8NCT3
MKPESDRPRKVRFRI

GRXCR1

6

A8MXD5
APRSVMKSFIKRNTP

INCENP

511

Q9NQS7
RFIPDPKAGIMIKSV

KIT

161

P10721
VVEVKLPARMFESLP

INPP4B

716

O15327
LKAMIKTFRPALPVS

LENG8

741

Q96PV6
PVKVRFQEAEERPKM

HSPH1

701

Q92598
LPVAPFMDRDKVTKA

PDE9A

496

O76083
VPRPFRMTLREARKK

FAM161B

171

Q96MY7
RFPRTPMSVEIKGKN

GDPD3

141

Q7L5L3
NAVVKMLPSFVRRTP

HK1

506

P19367
FPRRAQPKMVTRTKK

MSI1

96

O43347
PVTFLKNDDVAMPRK

PHOSPHO2

186

Q8TCD6
KVRKMPETFSNLPRT

NDFIP1

201

Q9BT67
RKMRDRNPKVAEIPF

ATP1A2

466

P50993
VRYQMPVPSKIPRKA

IL1RL1

531

Q01638
PEKYMRVASPSRKVQ

BRCA2

836

P51587
ERMPTPVIKAFGILK

FH

86

P07954
MRFTRKELERPIKVP

SLC7A9

396

P82251
IAFRTRSKMPLKDVP

GON4L

491

Q3T8J9
RKPDVTLDFMLPRKT

LYST

1621

Q99698
DRISKMFSPKVLAPQ

CCDC168

5791

Q8NDH2
KVVMKFDPGILPSIR

CFAP47

526

Q6ZTR5
SKPVTRAFPVMLLVR

PKD1L1

1606

Q8TDX9
DPREMRKTFIVPAIK

CAMSAP2

6

Q08AD1
PFRVPRAAILMKGTA

LRRC40

576

Q9H9A6
MTREKFPEKIPFRLT

MTOR

2366

P42345
VRFVILVLAPPKMKS

SLC4A11

231

Q8NBS3
PPMTVREKTRLEKFR

TBC1D22B

176

Q9NU19
RMSSFVEPPDIVKKL

PHF2

201

O75151
PKIAPMFRKKARVVI

TMEM185A

316

Q8NFB2
PRRIRMEDIKKAFPS

TAF1L

841

Q8IZX4
SQVIRKLVMEPTFKP

PITRM1

836

Q5JRX3
KKSMRKDPFFRISPR

ABCA8

1226

O94911
VLTVKFPKLMVPRFS

AHNAK2

5381

Q8IVF2
KVIAPLEAFKMPQRE

C10orf120

146

Q5SQS8
VRVPMSVVNFEKPKT

MRPL9

231

Q9BYD2
RVPRSGKPAELLKMF

TKT

591

P29401
IKREPNKFFVPRTVM

PYGM

591

P11217
FVKPSVRKGVLPRML

REV3L

2676

O60673
EPTLRKRKSPAQVMF

SLC2A4RG

186

Q9NR83
VITKSGRRMFPPFKV

TBX2

126

Q13207
KAGRRMFPSVRVKVK

TBX22

116

Q9Y458
AFRPVKSVKMAAPVK

SRGAP2

1021

O75044
KRKRMKRDQPAFTPS

XRN2

421

Q9H0D6
GKLEEQRPERVKPFM

TPT1

101

P13693
MTARRDPKPGAKRLV

FAM90A2P

1

Q658T7
RRKRKSYIVMSPESP

ZBTB44

181

Q8NCP5
IKRDPAKAFVPRTVM

PYGB

591

P11216
KPRIPMETFRKVGIP

TMPRSS4

21

Q9NRS4
QRPKRVKPFMTGAAE

nan

111

Q56UQ5
MVTPAKKRVFDVNRP

TSHZ2

316

Q9NRE2
KRVGVDRAFPLKPMV

ZC2HC1C

131

Q53FD0
LAPKRKAVEMHPAVT

ZC3H11B

666

A0A1B0GTU1
FIKRKRPKRSEPIME

ZCCHC18

226

P0CG32
VDRAVILFKPMVSEP

PPIP5K2

941

O43314
GPRPRVAVKMAFRKA

TIGD5

41

Q53EQ6
VKALRKARPGMVSTF

PTPRC

1201

P08575
RFGPKPMRIKEDILA

ZMYM3

1091

Q14202
KPEALPTKLRSMFRA

TRIM6

266

Q9C030
PTKLRSMFRAPDLKR

TRIM6

271

Q9C030
PMAVHRVKVTFKDEP

UBR5

2271

O95071
RTAVRFKPIQKEMTP

PIFO

76

Q8TCI5
SPAFALKNRIRMPTK

TPX2

486

Q9ULW0
MAPKFLTPLIDRVVV

MYBPC2

1046

Q14324
FRILQKKPRSMAEPE

MYPN

481

Q86TC9